Literature DB >> 9129543

Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.

R Bressler1, D G Johnson.   

Abstract

Non-insulin-dependent diabetes mellitus is a metabolic disease that is common and is characterized by insulin insufficiency and resistance. Measures such as body weight reduction and exercise improve the metabolic defects, but pharmacological therapy is the most frequently used and successful therapy. The sulphonylureas stimulate insulin secretion. Metformin and troglitazone increase disposal and decrease hepatic glucose output without causing hypoglycemia. Acarbose is a dietary aid that spreads the dietary carbohydrate challenge to endogenous insulin over time. These pharmacological agents, either alone or in combination, can improve blood glucose regulation in patients with non-insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129543

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  19 in total

Review 1.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.

Authors:  Valentina Medici; Stephen A McClave; Keith R Miller
Journal:  Curr Gastroenterol Rep       Date:  2016-01

3.  Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes.

Authors:  Ariela R Orkaby; Kelly Cho; Jean Cormack; David R Gagnon; Jane A Driver
Journal:  Neurology       Date:  2017-09-27       Impact factor: 9.910

Review 4.  The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.

Authors:  Rachel A Blair; Emily A Rosenberg; Nadine E Palermo
Journal:  Curr Diab Rep       Date:  2019-12-06       Impact factor: 4.810

Review 5.  Optimising therapy for insulin-treated type 2 diabetes mellitus.

Authors:  L S Hermann
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

Review 6.  Oral antidiabetic agents. A guide to selection.

Authors:  A J Scheen; P J Lefèbvre
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

Review 7.  Contemporary Medical Therapies for Patients with Peripheral Artery Disease and Concomitant Type 2 Diabetes Mellitus: a Review of Current Evidence.

Authors:  Dennis I Narcisse; Daniel R Katzenberger; J Antonio Gutierrez
Journal:  Curr Cardiol Rep       Date:  2022-02-24       Impact factor: 2.931

Review 8.  Diabetes medications: Impact on inflammation and wound healing.

Authors:  Jay J Salazar; William J Ennis; Timothy J Koh
Journal:  J Diabetes Complications       Date:  2015-12-19       Impact factor: 2.852

Review 9.  Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes.

Authors:  Olakunle Sanni; G Terre'Blanche
Journal:  Rev Endocr Metab Disord       Date:  2021-06-24       Impact factor: 6.514

10.  Interactions of rosiglitazone and anti-arrhythmic drugs in animal model.

Authors:  Ym Mohammed; Ei Mohammed; N Mohiuddin; Ss Syeda
Journal:  Ann Med Health Sci Res       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.